Nasdaq:US$12.13 (-0.47) | HKEX:HK$18.98 (-0.42) | AIM:£1.92 (-0.08)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate